DBV Technologies S.A.: DBV Technologies Reports Full-Year 2020 Financial Results and Recent Business Developments DBV Technologies Reports Full-Year 2020 Financial Results and Recent Business Developments DBV Technologies S.A. (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today reported financial results for the year ended December 31, 2020. The financials have been audited by the Company's statutory auditors and were approved by the Board of Directors on March 11, 2021. The audit report will be issued by the Company's auditors in March 2021. " DBV ended 2020 well positioned to advance Viaskin Peanut towards potential approval in both the United States and European Union," said Daniel Tasse, Chief Executive Officer of DBV Technologies. "